Drugs / Colposeptine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01153958 | Jul → Nov 2010 | bacterial vaginosis | Merck KGaA, Darmstadt, Germany | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colposeptine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153958 ↗ |
| Known as | Chlorquinaldol-Promestriene Vaginal Capsules | “Chlorquinaldol-Promestriene Vaginal Capsules” NCT01153958 ↗ |
| Route | Other | “administered transvaginally” NCT01153958 ↗ |